Andere Sprachen Nahdi Medical Company

Aktien

4164

SA15HG521213

4164

Schlusskurs Saudi Arabian S.E. Andere Börsenplätze 00:00:00 02.05.2024			% 5 Tage	% 1. Jan.
137,8 ^SAR	+0,29 %		+1,47 %	+0,58 %

18.03.	Nahdi Medical Company meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
18.03.	Nahdi Medical steigert Nettogewinn und Umsatz im GJ23	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2023	18.03.
Nahdi Medical Posts Higher FY23 Net Profit, Revenue	18.03.
Nahdi Medical Company Approves Cash Dividend Distribution for the Second Half of 2023	17.03.
Nahdi Medical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10.11.
OptiBiotix says market still "volatile" but partner sales improving	01.11.
Saudi Arabia healthcare group Fakeeh Care weighs IPO, appoints HSBC - sources	27.08.23
Nahdi Medical Company Reports Earnings Results for the Second Quarter Ended June 30, 2023	03.08.23
Nahdi Medical Company Reports Earnings Results for the First Quarter Ended March 31, 2023	11.05.23
Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2022	20.03.23
Nahdi Medical Company Reports Earnings Results for the Third Quarter Ended September 30, 2022	06.11.22
Nahdi Medical Company Reports Earnings Results for the Third Quarter Ended September 30, 2022	06.11.22
OptiBiotix Health gets approval to sell products in Saudi Arabia	24.10.22
OptiBiotix Health Plc Announces Exclusive Distributor Nahdi Medical Co Has Received Approval from the Saudi Food and Drug Authority for GoFigure Shakes and Bars Containing Patented Weight Management Aid Slimbiome	24.10.22
Nahdi Medical Company Announces the Establishment of a New Company, Owned by its Subsidiaries	29.09.22
Certain Ordinary Shares of Nahdi Medical Company are subject to a Lock-Up Agreement Ending on 20-SEP-2022.	20.09.22
Nahdi Medical Company(SASE:4164) added to S&P Global BMI Index	19.09.22
Nahdi Medical Company(SASE:4164) added to S&P Pan Arab Composite	19.09.22
Nahdi Medical Company Announces Distribution of Cash Dividend for First Half of 2022, Payable on August 25, 2022	09.08.22
Nahdi Medical Company(SASE:4164) added to FTSE All-World Index	30.03.22
Nahdi Medical Company has completed an IPO in the amount of SAR 5.109 billion.	20.03.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Nahdi Medical Company

Aktien

4164

SA15HG521213

4164

Andere Sprachen

Filter